Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64d1f9c01a928d73d5b14758b7cd12c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d3b6e03a92d64f0e4893a8b297f7647 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-021 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-275 |
filingDate |
2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc72658228c0160b075a960780b218f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd4312599963c1b807e3332868a5da6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef061b2a2a4083157ece3ce3ac17ce32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e42bfe153c4d24d06d576c2735806e7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3fc5ae8fb7c68bbd33cf7a362fe4dc9 |
publicationDate |
2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1496939-A2 |
titleOfInvention |
Modified cea nucleic acid and expression vectors |
abstract |
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid. |
priorityDate |
2002-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |